Old Web
English
Sign In
Acemap
>
authorDetail
>
Klaus Edvardsen
Klaus Edvardsen
GlaxoSmithKline
Medicine
Follicular lymphoma
Ofatumumab
Rituximab
Immunology
3
Papers
59
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma
2013
Blood
Matthew J. Matasar
Myron S. Czuczman
Maria Alma Rodriguez
Michael Fennessy
Thomas C. Shea
Gary Spitzer
Izidore S. Lossos
Mohamed A. Kharfan-Dabaja
Robin Joyce
Luis Fayad
Kristen Henkel
Qiming Liao
Klaus Edvardsen
Roxanne C. Jewell
Doug Fecteau
Rajendra P. Singh
Steen Lisby
Craig H. Moskowitz
Show All
Source
Cite
Save
Citations (50)
A Phase II Study of Ofatumumab in Combination with ICE or DHAP Chemotherapy in Relapsed or Refractory Aggressive B-Cell Lymphoma Prior to Autologous Stem Cell Transplantation (ASCT)
2011
Blood
Matthew J. Matasar
Myron S. Czuczman
Maria Alma Rodriguez
Michael Fennessy
Thomas C. Shea
Gary Spitzer
Izidore S. Lossos
Mohamed A. Kharfan-Dabaja
Robin Joyce
Luis Fayad
Qiming Liao
Klaus Edvardsen
Steen Lisby
Craig H. Moskowitz
Show All
Source
Cite
Save
Citations (9)
Prévention d'une éruption cutanée sur des patients subissant une thérapie anti-egfr
2007
Klaus Edvardsen
Steen Lisby
Ole Baadsgaard
Show All
Source
Cite
Save
Citations (0)
1